GlassScriptPhysician profile
Joseph Lange
NPI 1639878671
$2,345.12
in general payments reported to CMS, 2019-2025
13 companies · $2,266 in 2025
The $2,266 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.10 · 2024: $64.26 · 2025: $2,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,448 · Travel and Lodging: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,447.61 |
| Travel and Lodging | $897.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $671.43 | 2025 | Iconix, Gamma, Mako |
| Arthrex, INC. | $632.40 | 2025 | |
| Oak Med, INC. | $625.63 | 2025 | |
| Bone Support INC. | $133.18 | 2025 | Ceramentbone Void Filler, Cerament G |
| Depuy Synthes Sales INC. | $91.70 | 2025 | Healix Knotless Peek, Rigidloop, Twistr |
| Orthofix Medical, INC. | $36.30 | 2023-2025 | Physio-Stim |
| Ferring Pharmaceuticals INC. | $35.44 | 2025 | Euflexxa |
| Aroa Biosurgery Incorporated | $24.55 | 2024 | |
| Nalu Medical, INC. | $21.62 | 2024 | Nalu Neurostimulation System |
| Cerapedics INC. | $18.67 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Vertex Pharmaceuticals Incorporated | $18.31 | 2025 | |
| Linvatec Corporation | $18.09 | 2024 | Biobrace 23mm |
| Curonix LLC | $17.80 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lange listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.